Quality of Life and Cosmetic Result of Single-port Access Endoscopic Thyroidectomy via Axillary Approach in Patients with papillary thyroid carcinomaAugust 18, 2016
[OncoTargets and Therapy] This research reviews the effects of single-port access transaxillary totally endoscopic thyroidectomy on outcomes following surgery, including quality of life and cosmetic result, in patients with papillary thyroid carcinoma (PTC).
Patients with medullary thyroid cancer who harbor RET M918T or RAS mutations may derive greater clinical benefit from cabozantinib compared with patients who do not have those genetic mutations.
There were no effective therapeutic options for advanced thyroid cancer until 5 years ago.
Scientists developed an innovative nanoplatform to more effectively deliver RNA interference to anaplastic thyroid cancer (ATC) sites. ATC is the most aggressive form of thyroid cancer; mortality is almost 100% and median survival is 3 to 5 months.
In women of reproductive age who have thyroid cancer, their remaining egg supply is affected by radioactive iodine treatment, potentially reducing their fertility.
Review found increased odds for developing thyroid or breast cancer as secondary malignancy after the other cancer type was diagnosed.
Treatment with sorafenib in patients with progressive metastatic medullary thyroid cancer (MTC) is well tolerated and resulted in disease control.
Elderly patients can safely undergo thyroid surgery with careful preoperative screening. The procedure was found to be no more dangerous in patients older than 65 years than in those ages 21 to 35 years.
Survivors of thyroid cancer report their quality of life after diagnosis and treatment as poor compared with patients whose diagnoses are more lethal cancers.
To test thyroid malignancy, many biomarkers are tested separately to confirm cancer. However, new research shows that the tests used to measure 2 major biomarkers in the diagnosis of thyroid cancer may be inaccurate.
A recent discovery may lead to the development of a cell-based regenerative therapy for restoring thyroid function in cancer patients after thyroidectomy and in children born with congenital hypothyroidism.
New, evidence-based recommendations from the American Thyroid Association will help guide the management of thyroid nodules. The new guidelines also focus on diagnosis and management of DTC, an increasingly prevalent form of cancer.
Children living near the Fukushima nuclear meltdowns in Japan have a much higher rate of thyroid cancer diagnoses than that of children elsewhere.
Positive link made between obesity and papillary, follicular, and anaplastic thyroid cancer; inverse link for medullary thyroid cancer.
Low-risk cancers that are asymptomatic and presumably will not cause problems in the future are responsible for the rapid increase in the number of new thyroid cancer diagnoses over the past decade, according to a study.
What would be the ideal TSH level for patients after total thyroidectomy for cancer of the papillary thyroid?
When multiple HDAC inhibitors were tested in combination with the chemotherapy drug paclitaxel, class II HDAC inhibitors signaled through a newly discovered pathway to promote synergy with chemotherapy treatment.
The newly developed NIR contrast agents can aid surgeons is distinguishing the thyroid and parathyroid glands from each other and from the surrounding tissue.
Revised guidelines for thyroid cancer testing now both incorporate personalized medicine and the latest tests.
Moderate TSH suppression may be as beneficial as high suppression of the hormone responsible for driving the disease for patients with thyroid cancer.
Risk of dying from thyroid cancer was associated with metastasis to the lymph nodes.
American Thyroid Association (ATA) releases updated treatment guidelines for medullary thyroid carcinomaApril 23, 2015
The American Thyroid Association (ATA) has released updated guidelines for the diagnosis and treatment of medullary thyroid carcinoma (MTC), a revision of the original guidelines published in 2009.
A canine trained to identify cancer in urine samples by scent was able to differentiate thyroid cancer from benign status nearly 90 percent of the time.
Breast cancer survivors have a higher risk of developing thyroid cancer, especially within 5 years of their breast cancer diagnosis, according to a national database analysis.
Sunitinib (Sutent), a drug approved for treatment of several other cancers, may be an effective adjunctive treatment for patients with advanced differentiated thyroid cancer.
Detection of asymptomatic thyroid nodules has increased, and the majority of benign thyroid nodules examined did not lead to a diagnosis of thyroid cancer, according to a recent study.
Cancer researchers have identified a molecule linked to the survival of anaplastic thyroid carcinoma (ATC), a lethal tumor with no current effective therapies.
A trained scent dog is able to accurately identify presence of thyroid cancer in urine samples.
Female breast cancer survivors may be at an increased risk for developing thyroid cancer.
Dramatic improvement in progression-free survival in patients with advanced radioiodine-refractory thyroid cancer.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|